These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 336544)

  • 1. Suppression of immunity to Mycobacterium lepraemurium infection.
    Lefford MJ; Mackaness GB
    Infect Immun; 1977 Nov; 18(2):363-9. PubMed ID: 336544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of delayed type hypersensitivity against ultrasonicated Mycobacterium lepraemurium bacilli without simultaneous local reactivity against live bacilli or protective immunity.
    Løvik M; Closs O
    Clin Exp Immunol; 1983 Aug; 53(2):319-27. PubMed ID: 6349877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and suppression of cross-reactive antituberculosis immunity after Mycobacterium lepraemurium infection of mice.
    Lefford MJ; Logie PS
    Infect Immun; 1981 Mar; 31(3):1023-33. PubMed ID: 6785237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice.
    Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1979 Dec; 38(3):461-74. PubMed ID: 394891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection.
    Lefford MJ; Morgan R; Logie PS
    Infect Immun; 1980 Jun; 28(3):860-6. PubMed ID: 6995324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity and delayed-type hypersensitivity in C57BL mice after immunization with live Mycobacterium lepraemurium and sonicated bacilli.
    Closs O; Løvik M
    Infect Immun; 1980 Jul; 29(1):17-23. PubMed ID: 6995335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of delayed-type hypersensitivity during Mycobacterium lepraemurium infection in mice.
    Poulter LW; Lefford MJ
    Infect Immun; 1977 Aug; 17(2):439-46. PubMed ID: 330412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immunity against live Mycobacterium lepraemurium: a requirement for viable bacilli?
    Løvik M; Closs O
    Immunology; 1984 Sep; 53(1):165-73. PubMed ID: 6381292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium lepraemurium infection of nude athymic (nu/nu) mice.
    Lefford MJ
    Infect Immun; 1985 Jul; 49(1):190-6. PubMed ID: 3891623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BCG vaccination on Mycobacterium lepraemurium infection in a highly susceptible inbred mouse strain.
    Løvik M; Closs O
    Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):133-8. PubMed ID: 7027737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
    Roch F; Bach MA
    Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ultraviolet radiation on the pathogenesis of Mycobacterium lepraemurium infection in mice.
    Jeevan A; Gilliam K; Heard H; Kripke ML
    Exp Dermatol; 1992 Oct; 1(3):152-60. PubMed ID: 1365315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy.
    Turcotte R; Chaput J; Lemieux S
    Clin Exp Immunol; 1984 Apr; 56(1):97-104. PubMed ID: 6370521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phorbol myristate acetate, a tumor-promoting agent, on the growth of Mycobacterium lepraemurium in the mouse footpad.
    Tomioka H; Saito H
    Microbiol Immunol; 1983; 27(5):395-407. PubMed ID: 6353178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.
    Lefford MJ; Patel PJ; Poulter LW; Mackaness GB
    Infect Immun; 1977 Dec; 18(3):654-9. PubMed ID: 338487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.
    Jeevan A; Asherson GL
    Lymphokine Res; 1988; 7(2):129-40. PubMed ID: 3043114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacteria antibodies in M. lepraemurium murine infection.
    Bach MA; Hoffenbach A
    Acta Leprol; 1984; 2(2-4):403-11. PubMed ID: 6398599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in BALB/c mice following immunization with heat-killed Mycobacterium lepraemurium.
    Graham L; Navalkar RG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):121-8. PubMed ID: 6380152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. II. Production of interleukins 2, 4, and 6 and of interferon-gamma by draining lymph node cells.
    Roch F; Bach MA
    Clin Immunol Immunopathol; 1991 Sep; 60(3):443-54. PubMed ID: 1907533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro.
    Brett SJ; Butler R
    Immunology; 1986 Nov; 59(3):339-45. PubMed ID: 2431995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.